Home
Home Page
Recent Posts
Top Active Boards
Popular Posts
Biotech Tweets
Market Tweets
Energy Industry Tweets
Official IV Sponsor Page
My Content
My Boards
My Feed
My Library
My Links
Boards Search
Groups Directory
My Network
My Favorite Posters
My Private Message Groups
My Blocked Sender List
Member Directory
Account
Email & Password
Subscription/Membership
All Account Details
My Profile
My Device Info
Sign Up
Settings
My Site Settings
My Notification Settings
BOARDS
Sign In for Filters
|
BOARDS
Become a Member
|
Sign In
Advertise With Us
Board Stats
:
19 members / 242 guests [89]
Axsome Therapeutics, Inc.
Board
Links
(more...)
Y!
AXSM / Message Board
BOARD
GROUPS
Loading...
Written By
On Topic Only
--
All Messages
Hide Replies
Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
Go to Msg #
MSG #
SUBJECT
TYPE
AUTHOR
SENTIMENT
RECS
DATE POSTED
1583
Re: WK11 was Auvelity's Best Script Week
GN
fairvalueforyou
3
9/22/2023 11:53:38 AM
1582
Re: WK11 was Auvelity's Best Script Week
GN
smittyfrmpa
1
9/22/2023 9:39:44 AM
1581
WK11 was Auvelity's Best Script Week
GN
biobetter
5
9/22/2023 9:06:20 AM
1580
Re: MDD competition in new listing, Neumora, NMRA
GN
biobetter
2
9/15/2023 6:05:56 PM
1579
Re: MDD competition in new listing, Neumora, NMRA - Here is NMRA corp presentation
GN
Biotech_Jim
1
9/15/2023 4:26:50 PM
1578
Re: MDD competition in new listing, Neumora, NMRA - Here is NMRA corp presentation
GN
fairvalueforyou
0
9/15/2023 4:21:24 PM
1577
MDD competition in new listing, Neumora, NMRA
GN
Biotech_Jim
0
9/15/2023 3:55:26 PM
1576
AXSM TA
GN
BelieverTim
1
9/15/2023 9:43:44 AM
1575
5145 Script count is good considering no Monday
GN
biobetter
5
9/15/2023 8:35:21 AM
1574
Latest Auvelity user's review from September 2023
GN
fairvalueforyou
4
9/14/2023 11:35:40 AM
Go to Msg #
About Us
•
Contact Us
•
Follow Us on Twitter
•
Members Directory
•
Help Center
•
Advertise
•
Official IV Sponsor Page
Become a Patron
© 2003-2023 Investorvillage.com. All rights reserved.
User Agreement
Financial Market Data provided by
.
Loading...